Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: April 9, 2007
Last updated: April 14, 2015
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 4, 2013